Lisa Wilson | Investor Relations |
Brian Markison | Chief Executive Officer |
Andrew Einhorn | Chief Financial Officer |
JD Schaub | Chief Operating Officer |
Randall Stanicky | RBC Capital Markets |
Good day, ladies and gentlemen, and welcome to the Osmotica Pharmaceuticals First Quarter 2019 Financial and Business Update Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today’s conference, Ms. Lisa Wilson, Investor Relations for Osmotica Pharmaceuticals. Ma’am, you may begin.